Brendan Hannah
Director of Finance/CFO bij QUINCE THERAPEUTICS, INC.
Vermogen: 207 602 $ op 30-04-2024
Actieve functies van Brendan Hannah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| QUINCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 16-03-2023 | - |
| Chief Operating Officer | 24-10-2023 | - | |
| Director of Finance/CFO | 16-03-2023 | - | |
| Corporate Officer/Principal | 01-05-2022 | 16-03-2023 | |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Chief Operating Officer | - | - |
Loopbaan van Brendan Hannah
Eerdere bekende functies van Brendan Hannah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | - | 01-12-2016 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Opleiding van Brendan Hannah
| University of California | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
- Beurs
- Insiders
- Brendan Hannah
- Ervaring
